Outsourced Pharma Webinars

  1. Foundations And Implications For International Reference Pricing 5/14/2026

    Reforms like the U.S. Most Favored Nation model are intensifying pressure on global launch strategies. Understand the tactics that protect value while expanding access.

  2. The Growing Role Of Real-World Evidence 5/14/2026

    Regulators and HTA bodies are raising the bar on real-world evidence. Understand how JCAs, oncology registries, and EHR data are redefining what credible RWE looks like, and how to meet agency expectations.

  3. Optimizing Outcomes In ADC Manufacturing 5/13/2026

    As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance.

  4. Design Scalable Downstream Processes With Practical Strategies 5/11/2026

    Downstream purification is becoming more complex as new modalities enter development. Learn how advanced analytics and chromatography strategies can support scalable, confident process development.

  5. A Systematic Approach To Assess Biologics Developability 5/8/2026

    Discover how a systematic, data-driven developability workflow can accelerate biologic formulation development, identify risks earlier, and optimize stability and manufacturability.

  6. From Insights To Impact: Predictive Models And PAT For More Efficient And Robust Biologics Manufacturing 5/8/2026

    Explore how advanced scale-up methodologies and real-time analytical technologies strengthen both drug substance and drug product manufacturing by enabling process understanding and informed decision-making.

  7. Spray Dried Biologics For Pulmonary Dosage Forms 5/8/2026

    View how spray drying enables stable, precisely engineered pulmonary powders for biologics, supporting efficient lung delivery, scalability, and preservation of molecular structure and activity.

  8. Early Developability Assessment For Antibody Based Therapeutics 5/7/2026

    Learn how an integrated developability and immunosafety toolbox can help de-risk multi-specific antibody development, improve candidate selection, and accelerate complex biologics toward the clinic.

  9. Enhancing Gene Editing Outcomes And Safety for Clinical Translation 5/6/2026

    Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.

  10. Spray Dried Biologics For Nasal Dosage Forms 5/5/2026

    A fireside chat explores spray drying for nasal biologics, covering formulation science, particle design, delivery advantages, and testing strategies to move from concept to clinic.